Isotechnika Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Isotechnika

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (72)	6/2/2003 4:08:01 AM
From: Icebrg	Read Replies (1) of 285

Transplant Pioneer Rejects Approach He Helped Create By MICHAEL WALDHOLZ Staff Reporter of THE WALL STREET JOURNAL For many years, doctors couldn't figure out if Dorothea Seaborn was merely lucky or an important clue to solving a longstanding medical mystery. Now, 40 years after she received one of the world's first kidney transplants, the 55-year-old Texas homemaker is helping doctors transform the field of transplant medicine.... Message 18993037 Perhaps not quite what Isotecchnika would like to see. Having almost created the perfect transplantation drug they may now be told it is not needed any more. At least not for lifelong treatments. In a way the method described in the article seems to be very similar to the Allomune system that BioTransplant tried to introduce. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next